Altre lingue Arctic Bioscience

Azioni

ABS

NO0010859580

Tempo reale Oslo Bors Altri mercati azionari 11:21:57 05/07/2024			Variaz. 5gg	Var. 1 gen.
10,5 ^NOK	-1,87%		0,00%	0,00%

26/06	Arctic Bioscience annuncia nuovi dati positivi che dimostrano gli effetti antinfiammatori degli esteri fosfolipidici di aringa nelle cellule immunitarie.	CI
01/03	Arctic Bioscience AS riporta i risultati degli utili per l'intero anno terminato il 31 dicembre 2023	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Arctic Bioscience - Mandatory notification of trade	02/07
Arctic Bioscience : New positive data showing anti inflammatory effects of phospholipid esters from herring roe in immune cells	26/06
.css 12qhwz2{background:url(https://backend.arctic bioscience.com/wp content/uploads/2021/04/cloud download.png) no repeat;float:left;width:24px;height:24px;margin right:10px;}Poster – Data on anti inflammatory cellular functions of herring roe oil	26/06
Arctic Bioscience - New positive data showing anti-inflammatory effects of phospholipid esters from herring roe in immune cells	26/06
Arctic Bioscience Announces New Positive Data Showing Anti-Inflammatory Effects of Phospholipid Esters from Herring Roe in Immune Cells	26/06
Arctic Bioscience - Q1 2024 Operational update - Progress according to plan	29/04
Arctic Bioscience - Minutes of the Annual General Meeting	26/04
Arctic Bioscience : Annual General Meeting 2024	26/04
Arctic Bioscience - Notice of Annual General Meeting on 26 April 2024	12/04
Arctic Bioscience - Annual report 2023	09/04
Arctic Bioscience - Extension of share options to members of management group	15/03
Arctic Bioscience AS Reports Earnings Results for the Full Year Ended December 31, 2023	01/03
Arctic Bioscience - Q4 2023 Operational update - Foundation for an exciting 2024	01/03
Arctic Bioscience Announces Treatment start for 519 patients in the HeROPA-Study	28/02
Arctic Bioscience - Treatment start for 519 patients in the HeROPA-study	28/02
Arctic Bioscience - Invitation to presentation of Q4 2023 operational update	22/02
Arctic Bioscience Completes Patient Enlistment for Psoriasis Drug Candidate’s Mid-stage Study	17/01
Arctic Bioscience - Recruitment completed in the phase IIb HeROPA clinical trial	17/01
Arctic Bioscience Announces Recruitment Completed in the Phase IIb HeROPA Clinical Trial	17/01
Financial calendar	15/12

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Arctic Bioscience

Azioni

ABS

NO0010859580

Altre lingue

Filtri